Corient Private Wealth
TLSA icon

Corient Private Wealth’s Tiziana Life Sciences TLSA Stock Holding History

Corient Private Wealth’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3K Sell
12,179
-12,279
-50% -$17.4K ﹤0.01% 2794
2025
Q4 		$36.4K Buy
24,458
+12,229
+100% +$22K ﹤0.01% 2689
2025
Q3 		$26.4K Buy
12,229
+2,052
+20% +$3.8K ﹤0.01% 2521
2025
Q2 		$16.1K Sell
10,177
-6,300
-38% -$8.42K ﹤0.01% 2416
2025
Q1 		$17.8K Buy
+16,477
New +$16.1K ﹤0.01% 2257

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Corient Private Wealth's TLSA Position: Q1 2026 in Review

Corient Private Wealth reduced its Tiziana Life Sciences (TLSA) stake by 50% in Q1 2026, selling an estimated $17.4K and leaving 12,179 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Corient Private Wealth first reported a position in TLSA in Q1 2025 and has held it in 5 quarters since. The position peaked at $36.4K in Q4 2025. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • Corient Private Wealth held 12,179 shares of Tiziana Life Sciences worth $14.3K as of Q1 2026.
  • Corient Private Wealth sold 12,279 Tiziana Life Sciences shares in Q1 2026, an estimated $17.4K.
  • Tiziana Life Sciences made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2794 holding.
  • Corient Private Wealth first reported a position in Tiziana Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Corient Private Wealth's Tiziana Life Sciences position peaked at $36.4K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.